PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 26 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Mechanism of action
Clinical evidence
A therapeutic combination of Maharasnadi kwatha (20 ml with equal water twice daily), Vatari guggulu, and Narayan taila significantly reduced Visual analogue scale (VAS) and WOMAC scores over 12 weeks [PMID:28757225].
Maharasnadi kashayam (15ml thrice daily) was used as part of an Ayurvedic treatment regimen to determine changes in balance indices [PMID:19439847].
Safety & adverse effects
Dosage & administration
Evidence summary
PubMed sources
- 1.PMID: 28757225 (2017) — Clinical evaluation of Vatari guggulu, Maharasnadi kwatha and Narayan taila in the management of osteoarthritis knee. · Journal of Ayurveda and integrative medicine
- 2.PMID: 19439847 (2009) — Improvement of balance in progressive degenerative cerebellar ataxias after Ayurvedic therapy: a preliminary report. · Neurology India
- 3.PMID: 22529677 (2012) — A comparison of the antioxidant property of five Ayurvedic formulations commonly used in the management of vata vyadhis. · Journal of Ayurveda and integrative medicine